title: Response to comment on: Bosi et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 2013;36:2887-2894.
authors.affiliation: Corresponding author: Emanuele Bosi, bosi.emanuele@hsr.it.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Bosi
authors.forename: Marina
authors.initials: M
authors.lastname: Scavini
authors.forename: Antonio
authors.initials: A
authors.lastname: Ceriello
authors.forename: Domenico
authors.initials: D
authors.lastname: Cucinotta
authors.forename: Antonio
authors.initials: A
authors.lastname: Tiengo
authors.forename: Raffaele
authors.initials: R
authors.lastname: Marino
authors.forename: Erminio
authors.initials: E
authors.lastname: Bonizzoni
authors.forename: Francesco
authors.initials: F
authors.lastname: Giorgino
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents